These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17713472)

  • 1. Inter-rater reliability of a classification system for hospital adverse drug event reports.
    Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
    Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.
    Kunac DL; Reith DM; Kennedy J; Austin NC; Williams SM
    Qual Saf Health Care; 2006 Jun; 15(3):196-201. PubMed ID: 16751470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
    Hougland P; Xu W; Pickard S; Masheter C; Williams SD
    Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
    Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
    Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quality of published adverse drug event reports.
    Kelly WN
    Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the assessment of preventable adverse drug events in daily clinical practice.
    van Doormaal JE; Mol PG; van den Bemt PM; Zaal RJ; Egberts AC; Kosterink JG; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):645-54. PubMed ID: 18338767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug events in emergency department population: a prospective Italian study.
    Trifirò G; Calogero G; Ippolito FM; Cosentino M; Giuliani R; Conforti A; Venegoni M; Mazzaglia G; Caputi AP
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):333-40. PubMed ID: 15682429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving medication administration error reporting systems. Why do errors occur?
    Wakefield BJ; Wakefield DS; Uden-Holman T
    Ambul Outreach; 2000; ():16-20. PubMed ID: 11067442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(15):380-3. PubMed ID: 15843786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internally-developed electronic reporting system for medication errors.
    Relihan E; Silke B; O'Grady F
    Ir Med J; 2009; 102(7):223-4. PubMed ID: 19772005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events in hospitalized cardiac patients.
    Fanikos J; Cina JL; Baroletti S; Fiumara K; Matta L; Goldhaber SZ
    Am J Cardiol; 2007 Nov; 100(9):1465-9. PubMed ID: 17950809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability.
    Hohmann C; Eickhoff C; Klotz JM; Schulz M; Radziwill R
    J Clin Pharm Ther; 2012 Jun; 37(3):276-81. PubMed ID: 21790687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.